"OncoVIDA es la Red Oncológica más grande del país, con resolución integral del Cáncer y con la mayor cobertura a lo largo de todo Chile. La experiencia de sus profesionales avala la mejor y más completa atención, brindando seguridad y confianza a cada uno de sus pacientes y familiares, mediante Cobertura GES, Seguro Catastrófico (CAEC) o de Libre Elección. Nuestros servicios cubren quimioterapias ambulatoria, exámenes y procedimientos, cuidados paliativos y manejo del dolor, que pueden ser cubiertos por Isapres y Fonasa con cualquiera de nuestros médicos. Tenemos más de 20 años de servicio y hemos logrado nuestra Segunda Acreditación entregada por la Superintendencia de Salud, con el cumplimiento del 100% de sus características."

During the past decade, Oncovida conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oncovida" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator and "Orion Corporation, Orion Pharma" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Oncovida" are "Metastatic Renal Cell Carcinoma" (1 trials), "Prostatic Neoplasms" (1 trials) and "Renal Cell Carcinoma" (1 trials). Many other conditions were trialed in "Oncovida" in a lesser frequency.

Most popular intervention types in "Oncovida" are "Drug" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Androgen deprivation therapy (ADT)" (1 trials), "Darolutamide (Nubeqa, BAY1841788)" (1 trials), "Placebo" (1 trials), "bempegaldesleukin" (1 trials) and "cabozantinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Oncovida" are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Oncovida". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Oncovida, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Oncovida, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".